Sutro Biopharma Inc (STRO):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Sutro Biopharma Inc (STRO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10856
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sutro Biopharma Inc (Sutro Biopharma), formerly Fundamental Applied Biology Inc, discovers, develops and manufactures novel cancer medicines which include antibody-drug conjugates (ADC’s), bispecific antibodies, and antibody-based therapeutics targeting immuno-oncology pathways. Its pipeline portfolio includes STRO-001, a CD74 ADC for the treatment of multiple myeloma, lymphomas, diffuse large B-cell lymphoma (DLBCL) and Mantle cell lymphoma (MCL); STRO-002, targeting ovarian and endometrial cancer. The company develops its pipeline products through Xpress CF platform, a biochemical protein synthesis system which develops therapeutic proteins and discovers drugs for the treatment and prevention of diseases. Sutro Biopharma owns a manufacturing facility in San Carlos, California. The company works in partnership with various pharmaceutical and biotechnology companies for pre-clinical development of novel antibody drug conjugates. Sutro Biopharma is headquartered in South San Francisco, California, the US.

Sutro Biopharma Inc (STRO) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sutro Biopharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Sutro Biopharma Raises USD85.4 Million in Series E Financing 11
Sutro Biopharma Raises USD60 Million in Venture Financing 13
SutroVax Raises Funds Through Initial Financing Round 14
Sutro Biopharma Raises US$26 Million In Series D Financing 15
Sutro Biopharma Raises US$16.5 Million In Second Tranche Of Series C Financing 17
Partnerships 19
Sutro Biopharma and Leukemia & Lymphoma Society Enter into Partnership 19
Sutro Biopharma Amends Co-Development Agreement with Celgene 20
Sutro Biopharma Enters into Agreement with University of California, San Francisco 22
Sutro Biopharma Enters Into Co-Development Agreement With Memorial Sloan-Kettering Cancer Center 23
Sutro Biopharma Enters Into Co-Development Agreement With Sanofi Pasteur 24
Sutro Biopharma Enters Into Co-Development Agreement With Celgene 25
Licensing Agreements 26
Merck Enters into Licensing Agreement with Sutro Biopharma 26
EnWave Enters into License Agreement with Sutro Biopharma for powderREV Technology 27
EMD Serono Enters into Licensing Agreement with Sutro Biopharma 28
Sutro Biopharma Enters Into Licensing Agreement With Scripps Research Institute For Click Chemistry 29
Equity Offering 30
Sutro Biopharma Prices IPO of Shares for USD85 Million 30
SutroVax Spins Out from Sutro Biopharma 31
Sutro Biopharma Inc – Key Competitors 32
Sutro Biopharma Inc – Key Employees 33
Sutro Biopharma Inc – Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Recent Developments 35
Financial Announcements 35
Nov 14, 2018: Sutro Biopharma announces third quarter 2018 financial results 35
Corporate Communications 37
Nov 08, 2018: Sutro appoints industry veteran Shalini Sharp to board of directors 37
Sep 12, 2018: Sutro Biopharma names Worsley as Chief Business Officer and Linda Fitzpatrick as People and Communications Chief 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sutro Biopharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sutro Biopharma Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Sutro Biopharma Raises USD85.4 Million in Series E Financing 11
Sutro Biopharma Raises USD60 Million in Venture Financing 13
SutroVax Raises Funds Through Initial Financing Round 14
Sutro Biopharma Raises US$26 Million In Series D Financing 15
Sutro Biopharma Raises US$16.5 Million In Second Tranche Of Series C Financing 17
Sutro Biopharma and Leukemia & Lymphoma Society Enter into Partnership 19
Sutro Biopharma Amends Co-Development Agreement with Celgene 20
Sutro Biopharma Enters into Agreement with University of California, San Francisco 22
Sutro Biopharma Enters Into Co-Development Agreement With Memorial Sloan-Kettering Cancer Center 23
Sutro Biopharma Enters Into Co-Development Agreement With Sanofi Pasteur 24
Sutro Biopharma Enters Into Co-Development Agreement With Celgene 25
Merck Enters into Licensing Agreement with Sutro Biopharma 26
EnWave Enters into License Agreement with Sutro Biopharma for powderREV Technology 27
EMD Serono Enters into Licensing Agreement with Sutro Biopharma 28
Sutro Biopharma Enters Into Licensing Agreement With Scripps Research Institute For Click Chemistry 29
Sutro Biopharma Prices IPO of Shares for USD85 Million 30
SutroVax Spins Out from Sutro Biopharma 31
Sutro Biopharma Inc, Key Competitors 32
Sutro Biopharma Inc, Key Employees 33
Sutro Biopharma Inc, Other Locations 34

List of Figures
Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Sutro Biopharma Inc (STRO):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Wheelabrator Technologies Inc.:企業のM&A・提携動向(発電分野)
    Summary Wheelabrator Technologies Inc. (Wheelabrator) is a clean energy company that produces clean energy and supplies renewable electric power through the conversion of municipal solid waste and various other renewable waste fuels. The company provides special waste services for defective, damaged …
  • NorthWestern Corporation (NWE)-石油・ガス分野:企業M&A・提携分析
    Summary NorthWestern Corporation, doing business as NorthWestern Energy, is an integrated electric utility which generates, transmits, and distributes electricity and distributes natural gas in South Dakota, Nebraska and Montana. It produces energy from wind, hydro, natural gas, and coal-fired sourc …
  • Cardinal Ethanol LLC (CRDE):企業の戦略的SWOT分析
    Cardinal Ethanol LLC (CRDE) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Kawasaki Heavy Industries Ltd (7012):企業の財務・戦略的SWOT分析
    Kawasaki Heavy Industries Ltd (7012) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • ION Geophysical Corporation (IO):企業のM&A・提携動向(石油・ガス分野)
    Summary ION Geophysical Corporation (ION) is a seismic solutions provider. It offers advanced seismic data acquisition equipment, software, and seismic processing and planning services to the global oil and gas industry. The company product portfolio comprises of land seismic data acquisition equipm …
  • Formosan Union Chemical Corp (1709):企業財務及び戦略的SWOT分析
    Summary Formosan Union Chemical Corp (FUCC) is a chemical company that develops, manufactures and trades a variety of chemicals. The company’s products include normal olefin, alkyl benzene, nonyl phenol, and hydrogenated petroleum resin. It also provides hydrogenated hydrocarbon resin, normal paraff …
  • Coms plc (COMS):企業概要、財務及び戦略的SWOT分析
    Summary Coms plc (Coms) is a telecommunication service provider. The company provides hosted VolP telephony solutions and services. Its products include hosted VolP telephone systems, enterprise and public sector systems, single lines, SIP trunking, headsets, leased lines, Vibe, mobile apps, broadba …
  • Cobra Gestion de Infraestructuras, S.A.U.:企業のM&A・提携動向(発電分野)
    Summary Cobra Gestion de Infraestructuras, S.A.U. (Grupo Cobra) is an engineering and infrastructure company that develops, builds, operates and maintains industrial facilities and power plants. The company’s business areas include renewable energy sources and the environment; industrial engineering …
  • EnergoMashinostroitelny Alliance:企業のM&A・提携動向(発電分野)
    Summary EnergoMashinostroitelny Alliance (EMAlliance), a subsidiary of Power Machines engineers, manufactures and supplies power generating equipment. The company’s products and services include: coal, gas and oil boilers; heat recovery steam generators for combined cycle power plants; circulating f …
  • Tourmaline Oil Corp.:企業のM&A・事業提携・投資動向
    Tourmaline Oil Corp. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Tourmaline Oil Corp. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • ViroPharma Incorporated:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' ViroPharma Incorporated Mergers …
  • Zijin Mining Group Co., Ltd.:企業のM&A・提携・投資分析
    Zijin Mining Group Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Zijin Mining Group Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Slavneft (SLAV):企業の財務及び戦略的SWOT分析
    Summary Slavneft (NGK Slavneft) is an oil and gas company. The company produces, sells and distributes oil products from exploration of hydrocarbon reserves and final oil products. Its products include oil and natural gas. The company has oil and gas exploration, development and production license a …
  • Galderma Laboratories, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Galderma Laboratories, Inc. Mer …
  • Adavale Resources Limited (ADD):企業の財務及び戦略的SWOT分析
    Summary Adavale Resources Limited (Adavale Resources) is a mining company that acquires, develops and explores mineral assets in Australia and Indonesia. The company’s projects include lake surprise project and Tapan project. Adavale Resources Tapan project, located in Indonesia is a thermal coal re …
  • Parker-Hannifin Corporation:企業の戦略・SWOT・財務情報
    Parker-Hannifin Corporation - Strategy, SWOT and Corporate Finance Report Summary Parker-Hannifin Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Iberdrola SA (IBE)-エネルギー分野:企業M&A・提携分析
    Summary Iberdrola, S.A. (Iberdrola) is an electric utility. The company generates, trades, transmits, distributes and markets electricity and gas. It operates hydroelectric, thermal and nuclear power plants in Spain and other countries. The company also involved in the production of electricity from …
  • Oleo e Gas Participacoes SA (OGXP3):企業のM&A・提携動向(石油・ガス分野)
    Summary Oleo e Gas Participacoes SA (OGX), a subsidiary of EBX Group is an oil and gas company that explores for oil and natural gas properties. The company has diversified portfolio of nineteen exploratory blocks located in offshore sedimentary basins in Brazil. It operates five blocks located in o …
  • Labindia Instruments Pvt. Ltd.:企業のM&A・提携動向(医療機器分野)
    Summary Labindia Instruments Pvt. Ltd. (Labindia) a subsidiary of Danaher Corporation is a medical equipment company that manufactures and markets analytical instruments and accessories. The company operates through three business segments such as nano bio process, bioscience and petroleum. It provi …
  • Rosenergoatom Concern:企業の戦略的SWOT分析
    Rosenergoatom Concern - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆